Interaction of isoflavonoids with human liver microsomal cytochromes P450: inhibition of CYP enzyme activities

References

• Allred CD, Ju YH, Allred KF, et al. (2001). Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein. Carcinogenesis 22:1667–73
   PubMed Web of Science ®Google Scholar
• Anderson GD, Rosito G, Mohustsy MA, Elmer GW. (2003). Drug interaction potential of soy extract and Panax ginseng. J Clin Pharmacol 43:643–8
   PubMed Web of Science ®Google Scholar
• Anzenbacher P, Anzenbacherova E. (2001). Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 58:737–47
   PubMed Web of Science ®Google Scholar
• Anzenbacher P, Zanger UM. (2012). Metabolism of drugs and other xenobiotics. Weinheim: Wiley-VCH Verlag GmbH
   Google Scholar
• Barnes S, Kirk M, Coward L. (1994). Isoflavones and their conjugates in soy foods – extraction conditions and analysis by HPLC mass-spectrometry. J Agric Food Chem 42:2466–74
   Web of Science ®Google Scholar
• Cassidy A, Brown JE, Hawdon A, et al. (2006). Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J Nutr 136:45–51
   PubMed Web of Science ®Google Scholar
• Doerge DR, Chang HC, Churchwell MI, Holder CL. (2000). Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab Dispos 28:298–307
   PubMed Web of Science ®Google Scholar
• Havsteen B. (1983). Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32:1141–8
   PubMed Web of Science ®Google Scholar
• Hawksworth G, Drasar BS, Hill MJ. (1971). Intestinal bacteria and the hydrolysis of glycosidic bonds. J Med Microbiol 4:451–9
   PubMed Web of Science ®Google Scholar
• Izumi T, Piskula MK, Osawa S, et al. (2000). Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr 130:1695–9
   PubMed Web of Science ®Google Scholar
• Kimura Y, Ito H, Ohnishi R, Hatano T. (2010). Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem Toxicol 48:429–35
   PubMed Web of Science ®Google Scholar
• Klejdus B, Vitamvasova-Sterbova D, Kuban V. (2001). Identification of isoflavone conjugates in red clover (Trifolium pratense) by liquid chromatography-mass spectrometry after two-dimensional solid-phase extraction. Analyt Chim Acta 450:81–97
   Web of Science ®Google Scholar
• Lamartiniere CA, Cotroneo MS, Fritz WA, et al. (2002). Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 132:552S–8S
   PubMed Web of Science ®Google Scholar
• Li X, Choi JS. (2007). Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats. Int J Pharm 337:188–93
   PubMed Web of Science ®Google Scholar
• Manach C, Williamson G, Morand C, et al. (2005). Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81:230S–42S
   PubMed Web of Science ®Google Scholar
• Messina M. (2000). Soyfoods and soybean phyto-oestrogens (isoflavones) as possible alternatives to hormone replacement therapy (HRT). Eur J Cancer 36:S71–2
   PubMed Web of Science ®Google Scholar
• Nakajima M, Itoh M, Yamanaka H, et al. (2006). Isoflavones inhibit nicotine C-oxidation catalyzed by human CYP2A6. J Clin Pharmacol 46:337–44
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano PR. (2005). Cytochrome P450: structure, mechanism, and biochemistry. New York: Kluwer Academic/Plenum Publishers
   Google Scholar
• Peng WX, Li HD, Zhou HH. (2003). Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers. Eur J Clin Pharmacol 59:237–41
   PubMed Web of Science ®Google Scholar
• Persky VW, Turyk ME, Wang L, et al. (2002). Effect of soy protein on endogenous hormones in postmenopausal women. Am J Clin Nutr 75:145–53
   PubMed Web of Science ®Google Scholar
• Phillips IR, Shephard EA. (2006). Cytochrome P450 protocols. Totowa, NJ: Humana Press
   Google Scholar
• Setchell KD, Brown NM, Desai P, et al. (2001). Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 131:1362S–75S
   PubMed Web of Science ®Google Scholar
• Setchell KD, Brown NM, Zimmer-Nechemias L, et al. (2002). Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 76:447–53
   PubMed Web of Science ®Google Scholar
• Shimada T, Tanaka K, Takenaka S, et al. (2010). Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives. Chem Res Toxicol 23:1921–35
   PubMed Web of Science ®Google Scholar
• Spencer JPE, Crozier A. (2012). Flavonoids and related compounds: bioavailability and functions. Boca Raton, FL: CRC Press
   Google Scholar
• Taneja I, Raju KS, Wahajuddin. (2015). Dietary isoflavones as modulators of drug metabolizing enzymes and transporters: effect on prescription medicines. Crit Rev Food Sci Nutr. [Epub ahead of print]. doi: 10.1080/10408398.2015.1045968
   PubMed Web of Science ®Google Scholar
• Tikkanen MJ, Adlercreutz H. (2000). Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention? Biochem Pharmacol 60:1–5
   PubMed Web of Science ®Google Scholar
• Tsujimoto M, Horie M, Honda H, et al. (2009). The structure-activity correlation on the inhibitory effects of flavonoids on cytochrome P450 3A activity. Biol Pharm Bull 32:671–6
   PubMed Web of Science ®Google Scholar
• Wang Y, Man Gho W, Chan FL, et al. (2008). The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression. Br J Nutr 99:303–10
   PubMed Web of Science ®Google Scholar
• Zanger UM, Schwab M. (2013). Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103–41
   PubMed Web of Science ®Google Scholar
• Zheng J, Chen B, Jiang B, et al. (2010). The effects of puerarin on CYP2D6 and CYP1A2 activities in vivo. Arch Pharm Res 33:243–6
   PubMed Web of Science ®Google Scholar